Close Menu

NEW YORK (GenomeWeb) – Agilent Technologies today said it named Alacris Theranostics an Agilent Certified Service Provider for target enrichment. 

Alacris is based in Berlin and provides molecular analysis and bioinformatics through an approach called ModCell, which is intended to match patients with appropriate therapies. According to Agilent, Alacris exploits next-generation sequencing and other omics data to facilitate drug development and personalized medicine in cancer and other complex diseases. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.

The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.

Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.

In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.